Literature DB >> 22695500

Enzyme-free detection and quantification of double-stranded nucleic acids.

Cécile Feuillie1, Maxime Mohamad Merheb, Benjamin Gillet, Gilles Montagnac, Catherine Hänni, Isabelle Daniel.   

Abstract

We have developed a fully enzyme-free SERRS hybridization assay for specific detection of double-stranded DNA sequences. Although all DNA detection methods ranging from PCR to high-throughput sequencing rely on enzymes, this method is unique for being totally non-enzymatic. The efficiency of enzymatic processes is affected by alterations, modifications, and/or quality of DNA. For instance, a limitation of most DNA polymerases is their inability to process DNA damaged by blocking lesions. As a result, enzymatic amplification and sequencing of degraded DNA often fail. In this study we succeeded in detecting and quantifying, within a mixture, relative amounts of closely related double-stranded DNA sequences from Rupicapra rupicapra (chamois) and Capra hircus (goat). The non-enzymatic SERRS assay presented here is the corner stone of a promising approach to overcome the failure of DNA polymerase when DNA is too degraded or when the concentration of polymerase inhibitors is too high. It is the first time double-stranded DNA has been detected with a truly non-enzymatic SERRS-based method. This non-enzymatic, inexpensive, rapid assay is therefore a breakthrough in nucleic acid detection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22695500     DOI: 10.1007/s00216-012-6133-1

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  2 in total

1.  Raman spectroscopy in biomedicine: new advances in SERRS cancer imaging.

Authors:  Cécile Feuillie
Journal:  Ann Transl Med       Date:  2015-12

2.  Detection of DNA sequences refractory to PCR amplification using a biophysical SERRS assay (Surface Enhanced Resonant Raman Spectroscopy).

Authors:  Cécile Feuillie; Maxime M Merheb; Benjamin Gillet; Gilles Montagnac; Isabelle Daniel; Catherine Hänni
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.